TCF20 and central nervous system cancer: Previous literature reported that TCF20 variation is associated with some severe neuropsychiatric disorders (e.g., schizophrenia, generalized anxiety disorder and seizure (Smeland et al., 2017; Vetrini et al., 2019; Lévy et al., 2022)) and the occurrence, development, metastasis and recurrence of multiple tumors (e.g., gliomas, meningiomas, and ovarian and colon cancers (Rekdal et al., 2000)).